Search

Peter M Cheifetz

from East Windsor, NJ
Age ~45
Get Report
Also known as:
Peter M Chiefetz, Cheifetz Cheifetz, Peter Sheifetz
Phone and address:
15 Lynnfield Dr, East Windsor, NJ 08520
(609) 448-1710
Related to:
Adam C Cheifetz, 24Claudette RussellAdelle CheifetzLauren Vaccaro, 44
Connected to:
Isaac Y Cheifetz, 64Robert A Cheiffetz, 67Gail Cheifitz, 65Sammy A Cheikelard, 38Ahmad S Cheikhali, 63Diop Cheikh, 68Moulaye O Cheikh, 57Josephine Cheiky, 36Alan M Cheiman, 64Alan J Cheinstein, 70

Peter Cheifetz Phones & Addresses

  • 15 Lynnfield Dr, Hightstown, NJ 08520 (609) 448-1710
  • East Windsor, NJ
  • 9223 Town Ct, Lawrence Twp, NJ 08648 (609) 269-5845
  • Lawrence Township, NJ
  • New Brunswick, NJ
  • Brookline, MA
  • Providence, RI
  • Burlington, MA

Education

Degree: Associate degree or higher

Publications

Us Patents

Parasiticidal Oral Veterinary Compositions Comprising Systemically-Acting Active Agents, Methods And Uses Thereof

View page
US Patent:
20130203692, Aug 8, 2013
Filed:
Jan 31, 2013
Appl. No.:
13/754969
Inventors:
Mark David Soll - Alpharetta GA, US
Diane Larsen - Buford GA, US
Susan Mancini Cady - Yardley PA, US
Peter Cheifetz - East Windsor NJ, US
Izabela Galeska - Newtown PA, US
Assignee:
MERIAL LIMITED - Duluth GA
International Classification:
A61K 45/06
C07D 261/04
A61K 31/27
A61K 31/7048
A61K 31/365
A61K 31/42
A61K 31/4985
US Classification:
514 30, 514378, 548240, 514368, 514256, 514250, 514155
Abstract:
This invention relates to oral veterinary compositions for combating ectoparasites and endoparasites in animals, comprising at least one systemically-acting active agent in combination with a pharmaceutically acceptable carrier. This invention also provides for improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.

Drug Delivery Formulations For Targeted Delivery

View page
US Patent:
20080193543, Aug 14, 2008
Filed:
May 17, 2006
Appl. No.:
11/914394
Inventors:
Joshua Reineke - Providence RI, US
Peter Matthew Cheifetz - Burlington MA, US
Bryan Laulicht - New Hyde Park NY, US
Edith Mathiowitz - Brookline MA, US
Assignee:
Brown University Research Foundation - Providence RI
International Classification:
A61K 9/16
A61N 2/00
US Classification:
424490, 424489, 600 9
Abstract:
The size and location of microsphere uptake/delivery are important determinants of the final biodistribution of oral microsphere systems. Formulations, kits, methods of administering the formulations, and using the kits are described herein. The formulations are oral dosage formulations. In one embodiment, the formulations contain microparticles and/or nanoparticles having a homogenous size range selected to optimize uptake in a specific region of the GI tract and target drug delivery to specific organs. In some embodiments, the dosage formulation contains an enteric coating and/or a magnetic material. In a preferred embodiment, the formulation contains a magnetic material and an active agent to be delivered, optionally the active agent is in the form of micro- or nano-particles. In some embodiments metallomucoadhesive materials and/or magnetic materials are employed as magnetic and/or mucoadhesive sources. Formulations containing magnetic materials can be localized using the kits and methods disclosed herein. In one embodiment, the method includes orally administering the formulation and applying an extracorporeal magnet to a site on the outside surface of the patient's body in an area that closely apposes the location in the gastrointestinal tract to which delivery of the formulation is desired. The extracorporeal magnet is applied for a suitable time period to allow for the drug to be released from the formulation and/or to allow for the formulation to adhere to the site. Both magnetic and mucoadhesive forces may be utilized to site-direct and retain the dosage form in the region of the gastrointestinal (GI) tract most suitable for the desired delivery.

Extended Release Injectable Formulations Comprising An Isoxazoline Active Agent, Methods And Uses Thereof

View page
US Patent:
20210299104, Sep 30, 2021
Filed:
May 24, 2021
Appl. No.:
17/327929
Inventors:
- DULUTH GA, US
Peter Cheifetz - East Windsor NJ, US
Izabela Galeska - Newtown PA, US
Loic Patrick Le Hir de Fallois - Hopewell NJ, US
Assignee:
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. - Duluth GA
International Classification:
A61K 31/42
A61K 9/00
A61K 31/422
A61K 47/22
A61K 47/10
Abstract:
This invention relates to extended release injectable formulations for combating parasites in animals, comprising at least one isoxazoline active agent, a pharmaceutically acceptable polymer, and a solvent. This invention also provides for improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the extended release injectable formulations of the invention to the animal in need thereof.

Parasiticidal Oral Veterinary Compositions Comprising Systemically-Acting Active Agents, Methods And Uses Thereof

View page
US Patent:
20200179345, Jun 11, 2020
Filed:
Feb 12, 2020
Appl. No.:
16/788750
Inventors:
- DULUTH GA, US
Diane Larsen - Buford GA, US
Susan Mancini Cady - Yardley PA, US
Peter Cheifetz - East Windsor NJ, US
Izabela Galeska - Newtown PA, US
Saijun Gong - Bridgewater NJ, US
Assignee:
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. - DULUTH GA
International Classification:
A61K 31/42
A61K 47/42
A61K 31/325
A01N 43/80
A61K 31/194
A61K 47/44
A61K 47/36
A61K 47/32
A61K 47/14
A61K 9/00
A61K 47/12
A61K 47/10
A61K 31/437
A23K 20/00
A61K 31/27
A61K 31/365
A61K 31/7048
A61K 31/4985
C07D 261/04
A61K 45/06
Abstract:
This invention relates to oral veterinary compositions for combating ectoparasites and endoparasites in animals, comprising at least one systemically-acting active agent in combination with a pharmaceutically acceptable carrier. This invention also provides for improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.

Antiparasitic Isoxazoline Compounds, Long-Acting Injectable Formulations Comprising Them, Methods And Uses Thereof

View page
US Patent:
20200038370, Feb 6, 2020
Filed:
Aug 7, 2019
Appl. No.:
16/534912
Inventors:
- Duluth GA, US
Charles Q. Meng - Grayson GA, US
Susan Mancini Cady - Yardley PA, US
Peter Cheifetz - East Windsor NJ, US
Izabela Galeska - Newtown PA, US
Assignee:
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. - DULUTH GA
International Classification:
A61K 31/415
A61K 31/42
A61K 31/422
C07D 413/04
A61K 47/14
C07D 491/107
C07D 261/04
C07D 471/04
A01N 43/80
A61K 9/00
A61K 47/10
Abstract:
This invention relates to long-acting injectable compositions for combating parasites in animals, comprising at least one isoxazoline active agent, a liquid PEG and/or a neutral oil, optionally a co-solvent, and optionally a pharmaceutically acceptable additive or excipient. This invention also provides new isoxazoline active agents with long-lasting efficacy against ectoparasites. The invention also provides for improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the novel isoxazoline compounds and long-acting injectable compositions of the invention to the animal in need thereof.

Parasiticidal Oral Veterinary Compositions Comprising Systemically-Acting Active Agents, Methods And Uses Thereof

View page
US Patent:
20180185336, Jul 5, 2018
Filed:
Feb 26, 2018
Appl. No.:
15/904798
Inventors:
- Duluth GA, US
Diane Larsen - Buford GA, US
Susan Mancini Cady - Yardley PA, US
Peter Cheifetz - East Windsor NJ, US
Izabela Galeska - Newtown PA, US
Saijun Gong - Bridgewater NJ, US
Assignee:
MERIAL INC. - DULUTH GA
International Classification:
A61K 31/42
A61K 31/365
A61K 31/4985
A61K 31/27
A61K 31/437
A61K 9/00
A61K 47/10
A61K 47/12
A61K 47/14
A61K 47/32
A61K 47/36
A61K 47/44
A61K 31/7048
C07D 261/04
A61K 45/06
A23K 20/00
A61K 47/42
A61K 31/325
A01N 43/80
A61K 31/194
Abstract:
This invention relates to oral veterinary compositions for combating ectoparasites and endoparasites in animals, comprising at least one systemically-acting active agent in combination with a pharmaceutically acceptable carrier. This invention also provides for improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.

Antiparasitic Isoxazoline Compounds, Long-Acting Injectable Formulations Comprising Them, Methods And Uses Thereof

View page
US Patent:
20170239218, Aug 24, 2017
Filed:
Feb 24, 2017
Appl. No.:
15/441297
Inventors:
- DULUTH GA, US
Charles Q. Meng - Grayson GA, US
Susan Mancini Cady - Yardley PA, US
Peter Cheifetz - East Windsor NJ, US
Izabela Galeska - Newtown PA, US
Assignee:
MERIAL INC. - DULUTH GA
International Classification:
A61K 31/415
A61K 9/00
A61K 47/10
A01N 43/80
Abstract:
This invention relates to long-acting injectable compositions for combating parasites in animals, comprising at least one isoxazoline active agent, a liquid PEG and/or a neutral oil, optionally a co-solvent, and optionally a pharmaceutically acceptable additive or excipient. This invention also provides new isoxazoline active agents with long-lasting efficacy against ectoparasites. The invention also provides for improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the novel isoxazoline compounds and long-acting injectable compositions of the invention to the animal in need thereof.

Extended Release Injectable Formulations Comprising An Isoxazoline Active Agent, Methods And Uses Thereof

View page
US Patent:
20170020848, Jan 26, 2017
Filed:
Apr 6, 2016
Appl. No.:
15/092491
Inventors:
- DULUTH GA, US
Peter Cheifetz - East Windsor NJ, US
Izabela Galeska - Newtown PA, US
Loic Le Hir de Fallois - Atlanta GA, US
Assignee:
MERIAL INC. - DULUTH GA
International Classification:
A61K 31/42
A61K 9/00
Abstract:
This invention relates to extended release injectable formulations for combating parasites in animals, comprising at least one isoxazoline active agent, a pharmaceutically acceptable polymer, and a solvent. This invention also provides for improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the extended release injectable formulations of the invention to the animal in need thereof.
Control profile
Peter M Cheifetz from East Windsor, NJ, age ~45 Get Report